[HTML][HTML] Daratumumab, lenalidomide, and dexamethasone for multiple myeloma
MA Dimopoulos, A Oriol, H Nahi… - … England Journal of …, 2016 - Mass Medical Soc
Background Daratumumab showed promising efficacy alone and with lenalidomide and
dexamethasone in a phase 1–2 study involving patients with relapsed or refractory multiple …
dexamethasone in a phase 1–2 study involving patients with relapsed or refractory multiple …
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
MA Dimopoulos, A Oriol, H Nahi… - The New England …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Daratumumab showed promising efficacy alone and with lenalidomide and
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
[PDF][PDF] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
MA Dimopoulos, A Oriol, H Nahi, J San‑Miguel… - Medicine, 2016 - core.ac.uk
Syddansk Universitet Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Dimopoulos, Meletios A; Oriol, Albert; Na Page 1 Syddansk Universitet Daratumumab …
Dimopoulos, Meletios A; Oriol, Albert; Na Page 1 Syddansk Universitet Daratumumab …
Daratumumab, lenalidomide, and dexamethasone for multiple myeloma
MA Dimopoulos, A Oriol, H Nahi… - NEW ENGLAND …, 2016 - biblio.ugent.be
BACKGROUND: Daratumumab showed promising efficacy alone and with lenalidomide and
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
[引用][C] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
MA Dimopoulos, A Oriolo, H Nahi… - The New England …, 2016 - difusion.ulb.ac.be
[PDF][PDF] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
MA Dimopoulos, A Oriol, H Nahi, J San‑Miguel… - N Engl J Med, 2016 - bktimes.net
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma Page 1 The new
england journal of medicine n engl j med 375;14 nejm.org October 6, 2016 1319 established in …
england journal of medicine n engl j med 375;14 nejm.org October 6, 2016 1319 established in …
[PDF][PDF] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
MA Dimopoulos, A Oriol, H Nahi, J San‑Miguel… - N Engl J Med, 2016 - bktimes.net
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma Page 1 The new
england journal of medicine n engl j med 375;14 nejm.org October 6, 2016 1319 established in …
england journal of medicine n engl j med 375;14 nejm.org October 6, 2016 1319 established in …
Daratumumab, lenalidomide, and dexamethasone for multiple myeloma
POLLUX Investigators - New England …, 2016 - mdanderson.elsevierpure.com
BACKGROUND: Daratumumab showed promising efficacy alone and with lenalidomide and
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
MA Dimopoulos, A Oriol, H Nahi… - The New England …, 2016 - europepmc.org
Background Daratumumab showed promising efficacy alone and with lenalidomide and
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple …
[引用][C] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
MA Dimopoulos, A Oriol, H Nahi, J San-Miguel… - New England Journal …, 2016 - cir.nii.ac.jp